Bone-targeting radiopharmaceuticals for the treatment of bone-metastatic castration-resistant prostate cancer: exploring the implications of new data.
about
Targeting Bone Metastases in Metastatic Castration-Resistant Prostate CancerHealth Economics and Radium-223 (Xofigo®) in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Case History and a Systematic Review of the LiteratureRadium-223 dichloride in clinical practice: a review.Radium-223 for the treatment of castration-resistant prostate cancer.One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer.Radium-223 for primary bone metastases in patients with hormone-sensitive prostate cancer after radical prostatectomyRecent advances on the progressive mechanism and therapy in castration-resistant prostate cancer.
P2860
Q26752785-779F38AA-F40A-44B3-AC75-1876A4D0260AQ27004566-9A272AE1-1392-402B-B28F-D7C277FB6B83Q30251496-C1CF9D07-5981-4398-8A12-D998EF35852AQ35653986-29694A8F-8F40-437A-8701-4E4274C0D54BQ35822185-2336C3C5-C6BF-4419-B5E2-EFB612C93AC0Q41279824-C93DCFF6-2C53-465C-870D-6AC243E42AA9Q55343985-5D738D3C-822E-46CA-B486-AF9FD66BC1E5
P2860
Bone-targeting radiopharmaceuticals for the treatment of bone-metastatic castration-resistant prostate cancer: exploring the implications of new data.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Bone-targeting radiopharmaceut ...... the implications of new data.
@ast
Bone-targeting radiopharmaceut ...... the implications of new data.
@en
type
label
Bone-targeting radiopharmaceut ...... the implications of new data.
@ast
Bone-targeting radiopharmaceut ...... the implications of new data.
@en
prefLabel
Bone-targeting radiopharmaceut ...... the implications of new data.
@ast
Bone-targeting radiopharmaceut ...... the implications of new data.
@en
P2093
P2860
P1433
P1476
Bone-targeting radiopharmaceut ...... the implications of new data.
@en
P2093
Charles J Ryan
Jason J Everly
Oliver Sartor
Philip J Saylor
P2860
P304
P356
10.1634/THEONCOLOGIST.2013-0472
P577
2014-09-17T00:00:00Z